Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Your healthcare provider will establish a monitoring schedule tailored to your individual clinical situation, but general recommendations include specific metabolic, safety, and tolerability assessments
This combined effect has been shown in clinical studies to result in an average weight loss of over 20% of a patients body weight over 72 weeks
Tissue plasminogen activator binding to the annexin II tail domain
What Payers Will Now Require Updated weight and BMI measurements Documented lifestyle changes and adherence to treatment Evidence of beneficial response to therapy Up-to-date comorbidity diagnoses in the medical record Proof that the medication continues to be medically necessary Stricter Ongoing Monitoring Expect payers to require: More frequent follow-up visits Updated chart notes for each renewal Standardized metabolic labs Gaps in follow-up or incomplete documentation could lead to denialseven for medically qualified patients
US$ 21.33
US$ 23.37
US$ 22.38
